Cargando…

VirVACPRED: A Web Server for Prediction of Protective Viral Antigens

Viral antigens are key in the development of vaccines that prevent or eradicate infections caused by these pathogens. Bioinformatics tools are modern alternatives that facilitate the discovery of viral antigens, reducing the costs of experimental assays. We developed a bioinformatics tool called Vir...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrera-Bravo, Jesús, Farías, Jorge G., Contreras, Fernanda Parraguez, Herrera-Belén, Lisandra, Norambuena, Juan-Alejandro, Beltrán, Jorge F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679566/
https://www.ncbi.nlm.nih.gov/pubmed/34934411
http://dx.doi.org/10.1007/s10989-021-10345-2
_version_ 1784616552029487104
author Herrera-Bravo, Jesús
Farías, Jorge G.
Contreras, Fernanda Parraguez
Herrera-Belén, Lisandra
Norambuena, Juan-Alejandro
Beltrán, Jorge F.
author_facet Herrera-Bravo, Jesús
Farías, Jorge G.
Contreras, Fernanda Parraguez
Herrera-Belén, Lisandra
Norambuena, Juan-Alejandro
Beltrán, Jorge F.
author_sort Herrera-Bravo, Jesús
collection PubMed
description Viral antigens are key in the development of vaccines that prevent or eradicate infections caused by these pathogens. Bioinformatics tools are modern alternatives that facilitate the discovery of viral antigens, reducing the costs of experimental assays. We developed a bioinformatics tool called VirVACPRED, which is highly efficient in predicting viral antigens. In this study, we obtained a model based on the gradient boosting classifier, which showed high performance during the training, leave-one-out cross-validation (accuracy = 0.7402, sensitivity = 0.7319, precision = 0.7503, F1 = 0.7251, kappa = 0.4774, Matthews correlation coefficient = 0.4981) and testing (accuracy = 0.8889, sensitivity = 1.0, precision = 0.8276, F1 = 0.9057, kappa = 0.7734, Matthews correlation coefficient = 0.7941). VirVACPRED is a robust tool that can be of great help in the search and proposal of new viral antigens, which can be considered in the development of future vaccines against infections caused by viruses.
format Online
Article
Text
id pubmed-8679566
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-86795662021-12-17 VirVACPRED: A Web Server for Prediction of Protective Viral Antigens Herrera-Bravo, Jesús Farías, Jorge G. Contreras, Fernanda Parraguez Herrera-Belén, Lisandra Norambuena, Juan-Alejandro Beltrán, Jorge F. Int J Pept Res Ther Article Viral antigens are key in the development of vaccines that prevent or eradicate infections caused by these pathogens. Bioinformatics tools are modern alternatives that facilitate the discovery of viral antigens, reducing the costs of experimental assays. We developed a bioinformatics tool called VirVACPRED, which is highly efficient in predicting viral antigens. In this study, we obtained a model based on the gradient boosting classifier, which showed high performance during the training, leave-one-out cross-validation (accuracy = 0.7402, sensitivity = 0.7319, precision = 0.7503, F1 = 0.7251, kappa = 0.4774, Matthews correlation coefficient = 0.4981) and testing (accuracy = 0.8889, sensitivity = 1.0, precision = 0.8276, F1 = 0.9057, kappa = 0.7734, Matthews correlation coefficient = 0.7941). VirVACPRED is a robust tool that can be of great help in the search and proposal of new viral antigens, which can be considered in the development of future vaccines against infections caused by viruses. Springer Netherlands 2021-12-17 2022 /pmc/articles/PMC8679566/ /pubmed/34934411 http://dx.doi.org/10.1007/s10989-021-10345-2 Text en © The Author(s), under exclusive licence to Springer Nature B.V. 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Herrera-Bravo, Jesús
Farías, Jorge G.
Contreras, Fernanda Parraguez
Herrera-Belén, Lisandra
Norambuena, Juan-Alejandro
Beltrán, Jorge F.
VirVACPRED: A Web Server for Prediction of Protective Viral Antigens
title VirVACPRED: A Web Server for Prediction of Protective Viral Antigens
title_full VirVACPRED: A Web Server for Prediction of Protective Viral Antigens
title_fullStr VirVACPRED: A Web Server for Prediction of Protective Viral Antigens
title_full_unstemmed VirVACPRED: A Web Server for Prediction of Protective Viral Antigens
title_short VirVACPRED: A Web Server for Prediction of Protective Viral Antigens
title_sort virvacpred: a web server for prediction of protective viral antigens
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679566/
https://www.ncbi.nlm.nih.gov/pubmed/34934411
http://dx.doi.org/10.1007/s10989-021-10345-2
work_keys_str_mv AT herrerabravojesus virvacpredawebserverforpredictionofprotectiveviralantigens
AT fariasjorgeg virvacpredawebserverforpredictionofprotectiveviralantigens
AT contrerasfernandaparraguez virvacpredawebserverforpredictionofprotectiveviralantigens
AT herrerabelenlisandra virvacpredawebserverforpredictionofprotectiveviralantigens
AT norambuenajuanalejandro virvacpredawebserverforpredictionofprotectiveviralantigens
AT beltranjorgef virvacpredawebserverforpredictionofprotectiveviralantigens